CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Interventional Medicines

20-Feb-2006 - CombinatoRx, Incorporated and Angiotech Pharmaceuticals, Inc. announced a multi-year research and license agreement for the discovery, development, and potential commercialization by Angiotech of drug devices and interventional medicine products built from innovative drug combinations. The ...

Angiotech Announces Drug Discovery And Development Agreement with CombinatoRx

Exclusive Collaboration With Initial Focus on Peripheral Vascular, Coronary, and Orthopedic Indications

05-Oct-2005 - Angiotech Pharmaceuticals, Inc. announced a license and research collaboration agreement with CombinatoRx, Incorporated focused on the selection and development of novel combination pharmaceutical compounds for Angiotech's local interventional therapy applications. The collaboration significantly ...

Angiotech announces acquisition of Afmedica, Inc.

14-Sep-2005 - Angiotech Pharmaceuticals, Inc.announced that it has entered into a definitive agreement to acquire Afmedica, Inc., a private company developing perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease and end stage renal disease. The ...

Angiotech and Orthovita Announce Commercial Launch of Vitagel(TM)

17-Jan-2005 - Angiotech Pharmaceuticals, Inc. and Orthovita, Inc. announced that the companies have begun the official commercial launch of Vitagel(TM). Orthovita has initiated distribution through its 40 direct sales representatives and roughly 20 independent distributors. The direct representatives will have ...

Angiotech extends exclusive licensing agreement with Poly-Med for biomaterial technologies

15-Apr-2004 - Vancouver. Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, today announced that it has licensed a portfolio of biomaterial, drug delivery, and medical device technologies from Poly-Med, Inc. This agreement will expand ...